---
title: Dermatology CROs in Asia-Pacific
path: /indications/dermatology/apac
companies_count: 14
---

# Dermatology CROs in Asia-Pacific

14 published CROs match Dermatology in Asia-Pacific.

Locations in this set include United States, Australia, India, China, United Kingdom, and France.

Capabilities that show up most often in this set: Phase II Clinical Trials, Phase III Clinical Trials, Regulatory Affairs, Clinical Operations, and Phase IV / Post-Marketing.

## Matching companies

- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [Avion](/companies/avion)
  - Full-service CRO specializing in clinical trial management, advanced medical imaging, dosimetry, and data management across oncology, dermatology, and radiopharmaceutical therapies.
- [Clinical Research Network India Pvt. Ltd.](/companies/crnindia)
  - Clinical Research Organization offering Phase I–IV clinical trials, pharmacovigilance, medical writing, regulatory affairs, and data management services with 15+ years of experience across cardiology, oncology, vaccines, and medical devices.
- [Fortrea](/companies/fortrea)
  - Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.
- [KCAS Bio](/companies/kcasbio)
  - Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities.
- [MPREX](/companies/mprex)
  - MPREX is a contract research organization in Pune, India, specializing in clinical trials in dermatology and claim-substantiation studies for skin and hair care products, with laboratory testing for product efficacy and safety.
- [PPD](/companies/ppd)
  - PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Premier Research](/companies/premier-research)
  - Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
- [QPS](/companies/qps)
  - QPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
- [SPRIM PRO](/companies/sprim-pro)
  - Clinical trial and strategic consulting CRO offering innovation-enabled trial solutions, digital training, patient engagement programs, and regulatory consulting across multiple therapeutic areas including oncology, CNS, cardiovascular, and rare disease.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [TFS HealthScience](/companies/tfscro)
  - Global mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
- [WuXi AppTec](/companies/wuxiapptec)
  - Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.